|
(ÁÖ)À¯Æ¿·º½º |
ºñÀÓ»óÆÀ(¿¬±¸) ä¿ë
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.17 |
|
|
IQVIA |
CRA¸ðÁý°ø°í_IQVIA (urgent position) new
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.22 |
|
|
¾Ë¸®ÄÚÁ¦¾à(ÁÖ) |
[°æ·Â] Á¦¾à»ç ÀÓ»ó ´ã´çÀÚ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
08.17 |
|
|
IQVIA¢â |
Manager, Global Site Activation (Regulatory and Start-up
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.11 |
|
|
ÁÖ½Äȸ»ç ¹ÙÀÌ¿ÀÄÄÇø´ |
ºñÀÓ»ó ºÎ¹® ä¿ë
°¿ø °¸ª½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.01 |
|
|
(ÁÖ)Å¿õ¸ÞµðÄ® |
[ÀÓ»óÆÀ] CRA Á¤±ÔÁ÷ ¸ðÁý °ø°í (½ÅÀÔ&°æ·Â)
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.05 |
|
|
¿òÆ® |
ÀÓ»ó½ÃÇè CRM (Clinical Research Manager) °æ·ÂÁ÷ ä¿ë
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
ä¿ë½Ã |
05.19 |
|
|
(ÁÖ)¿Ã¸®ºêÇコÄɾî |
ÀÓ»ó »ó´ã Äݼ¾ÅÍ Á¤±ÔÁ÷ ä¿ë (½ÅÀÔÁö¿ø°¡´É)
°æ±â ¿ëÀνà | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.19 |
|
|
Á¸½¼¾ØµåÁ¸½¼ |
[Çѱ¹¾á¼¾] 2023 »ó¹Ý±â ±Û·Î¹ú ÀÓ»ó °æ·Â»ç¿ø ´ë±Ô¸ð °øä
¼¿ï ¿ë»ê±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.30 |
|
|
Á¸½¼¾ØµåÁ¸½¼ |
[Á¸½¼¾ØµåÁ¸½¼ ¸ÞµðÄ®] Clinical Research Specialist
¼¿ï ¿ë»ê±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.10 |
|
|
´õ¿þÀÌÄ¿¹Â´ÏÄÉÀÌ¼Ç |
ÀÓ»ó½ÃÇè CRA °æ·ÂÀÚ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
02.01 |
|
|
Å©¸®½ºÅ»Áö³ë¹Í½º(ÁÖ) |
ÀÓ»óPM / ÀÓ»óCRA / ÀÓ»óRA °æ·ÂÁ÷ ä¿ë
°æ±â ¼º³²½Ã ºÐ´ç±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
01.29 |
|
|
(ÁÖ)´ë¿õ¹ÙÀÌ¿À |
[´ë¿õ¹ÙÀÌ¿À] Á¦¾à»ç ÀÓ»ó½ÃÇè ´ã´çÀÚ °æ·Â ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
10³â¡è |
ä¿ë½Ã |
12.06 |
|
|
Å©¸®½ºÅ»Áö³ë¹Í½º(ÁÖ) |
ÀÓ»óPM ¹× ÀÓ»óCRA °æ·ÂÁ÷ ä¿ë
°æ±â ¼º³²½Ã ºÐ´ç±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
09.20 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
°æ·ÂPM ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
ä¿ë½Ã |
09.05 |
|